FIELD: biotechnology; medicine.
SUBSTANCE: invention represents polypeptides and transposase polynucleotides which have high activity in mammalian cells. Invention also relates to a method of providing a T-cell response using the disclosed transposase.
EFFECT: disclosed are transposase polypeptides and use thereof.
46 cl, 2 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| EXPRESSION OF NEW CELL MARKS | 2018 |
|
RU2796334C2 |
| CHIMERIC ANTIGEN RECEPTORS AND THEIR PRODUCTION METHODS | 2015 |
|
RU2753965C2 |
| CANCER TREATMENT USING CHIMERIC ANTIGEN-SPECIFIC RECEPTOR BASED ON HUMANISED ANTI-EGFRvIII ANTIBODY | 2014 |
|
RU2708032C2 |
| VCAR COMPOSITIONS AND METHODS OF USE | 2018 |
|
RU2820591C2 |
| INDUCED CASPASES AND METHODS FOR THEIR USE | 2017 |
|
RU2757058C2 |
| MUC16-SPECIFIC CHIMERIC ANTIGEN RECEPTORS AND THEIR USE | 2019 |
|
RU2795198C2 |
| TREATING CANCER BY HUMANISED ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR | 2014 |
|
RU2711975C2 |
| METHODS FOR PRODUCING CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTOR | 2015 |
|
RU2751362C2 |
| TRANSGENIC GENETIC LABELS AND METHODS OF USING | 2015 |
|
RU2729112C2 |
| MULTI-CHAIN CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF | 2013 |
|
RU2663725C2 |
